ABOUT INDEXING EDITORIAL BOARD ARCHIVES AUTHOR GUIDELINES SUBMIT PAPER NEWS, EVENTS AUTHOR'S PAGE CONTACT
Materiale Plastice
Cite as: Mater. Plast.
https://doi.org/10.37358/Mat.Plast.1964

OSIM Nr. R102356
ISSN Print 0025-5289
ISSN Online 2668-8220
Journal Metrics
* Impact factor 2019: 1.517
* 5-Year IF: 1.179
* CiteScore: 2.4
* H index: 22
Materiale Plastice - Latest Issue

Latest Issue >>>
ARCHIVES
   Volume 58, 2021
   Volume 57, 2020
   Volume 56, 2019
   Volume 55, 2018
   Volume 54, 2017
   Volume 53, 2016
   Volume 52, 2015
   Volume 51, 2014
   Volume 50, 2013
   Volume 49, 2012
   Volume 48, 2011
   Volume 47, 2010
   Volume 46, 2009
   Volume 45, 2008
   Volume 44, 2007
   Volume 43, 2006
   Volume 42, 2005
   Volume 41, 2004
   Volume 40, 2003
 
<<<< back

Materiale Plastice (Mater. Plast.), Year 2018, Volume 55, Issue 3, 299-302

https://doi.org/10.37358/MP.18.3.5017

Fawzia Shaat, Ramona Daniela Pavaloiu, Daniela Crina Salceanu, Cristina Hlevca, Gheorghe Nechifor

Evaluation of AML-VAL Nanoparticles as Combined Therapy in Cardiovascular Disease


Abstract:
The main aim of this study was to investigate a mixture of two poorly water-soluble active pharmaceutical ingredients (APIs): an angiotensin II receptor antagonist (valsartan) and a calcium channel blocker (amlodipine besylate), chosen in a fixed-dose, in order to obtain new polymeric nanoparticles (NPs) for cardiovascular diseases treatment. NPs were prepared via nanoprecipitation method using poly (D,L-lactide-co-glycolide) (PLGA) as matrix and Pluronic F127 as stabilizer. Three formulations were investigated with different ratios of AML:VAL:PLGA (1:16:5, 1:16:7.5 and 1:16:10). Particle size, polydispersity index and zeta-potential analyses were performed to characterize and optimize the formulation. The in vitro drug release study was determined by using a dialysis membrane method under sink conditions. All NPs loaded with both APIs showed nano-size, negative potential, a high homogeneity and a slow drugs release in physiological environment.


Keywords:
nanotechnology; cardiovascular; drug release; valsartan; amlodipine; PLGA

Issue: 2018 Volume 55, Issue 3
Pages: 299-302
Publication date: 2018/9/30
https://doi.org/10.37358/MP.18.3.5017
download pdf   Download Pdf Article
Creative Commons License
This article is published under the Creative Commons Attribution 4.0 International License
Citation Styles
Cite this article as:
SHAAT, F., PAVALOIU, R.D., SALCEANU, D.C., HLEVCA, C., NECHIFOR, G., Evaluation of AML-VAL Nanoparticles as Combined Therapy in Cardiovascular Disease, Mater. Plast., 55(3), 2018, 299-302.

Vancouver
Shaat F, Pavaloiu RD, Salceanu DC, Hlevca C, Nechifor G. Evaluation of AML-VAL Nanoparticles as Combined Therapy in Cardiovascular Disease. Mater. Plast.[internet]. 2018 Jul;55(3):299-302. Available from: https://doi.org/10.37358/MP.18.3.5017


APA 6th edition
Shaat, F., Pavaloiu, R.D., Salceanu, D.C., Hlevca, C. & Nechifor, G. (2018). Evaluation of AML-VAL Nanoparticles as Combined Therapy in Cardiovascular Disease. Materiale Plastice, 55(3), 299-302. https://doi.org/10.37358/MP.18.3.5017


Harvard
Shaat, F., Pavaloiu, R.D., Salceanu, D.C., Hlevca, C., Nechifor, G. (2018). 'Evaluation of AML-VAL Nanoparticles as Combined Therapy in Cardiovascular Disease', Materiale Plastice, 55(3), pp. 299-302. https://doi.org/10.37358/MP.18.3.5017


IEEE
F. Shaat, R.D. Pavaloiu, D.C. Salceanu, C. Hlevca, G. Nechifor, "Evaluation of AML-VAL Nanoparticles as Combined Therapy in Cardiovascular Disease". Materiale Plastice, vol. 55, no. 3, pp. 299-302, 2018. [online]. https://doi.org/10.37358/MP.18.3.5017


Text
Fawzia Shaat, Ramona Daniela Pavaloiu, Daniela Crina Salceanu, Cristina Hlevca, Gheorghe Nechifor,
Evaluation of AML-VAL Nanoparticles as Combined Therapy in Cardiovascular Disease,
Materiale Plastice,
Volume 55, Issue 3,
2018,
Pages 299-302,
ISSN 2668-8220,
https://doi.org/10.37358/MP.18.3.5017.
(https://revmaterialeplastice.ro/Articlegs.asp?ID=5017)
Keywords: nanotechnology; cardiovascular; drug release; valsartan; amlodipine; PLGA


RIS
TY - JOUR
T1 - Evaluation of AML-VAL Nanoparticles as Combined Therapy in Cardiovascular Disease
A1 - Shaat, Fawzia
A2 - Pavaloiu, Ramona Daniela
A3 - Salceanu, Daniela Crina
A4 - Hlevca, Cristina
A5 - Nechifor, Gheorghe
JF - Materiale Plastice
JO - Mater. Plast.
PB - Materiale Plastice SRL
SN - 2668-8220
Y1 - 2018
VL - 55
IS - 3
SP - 299
EP - 302
UR - https://doi.org/10.37358/MP.18.3.5017
KW - nanotechnology
KW - cardiovascular
KW - drug release
KW - valsartan
KW - amlodipine
KW - PLGA
ER -


BibTex
@article{MatPlast2018P299,
author = {Shaat Fawzia and Pavaloiu Ramona Daniela and Salceanu Daniela Crina and Hlevca Cristina and Nechifor Gheorghe},
title = {Evaluation of AML-VAL Nanoparticles as Combined Therapy in Cardiovascular Disease},
journal = {Materiale Plastice},
volume = {55},
number = {3},
pages = {299-302},
year = {2018},
issn = {2668-8220},
doi = {https://doi.org/10.37358/MP.18.3.5017},
url = {https://revmaterialeplastice.ro/Articlegs.asp?ID=5017}
}
<<<< back
 
  Search Authors
Crossref Member Badge
 DOI  logo
 Gold Open Access | Source=http://www.plos.org/  | Author=art designer at PLoS
Creative Commons License